KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Accumulated Expenses (2016 - 2025)

Pfizer (PFE) has disclosed Accumulated Expenses for 17 consecutive years, with $3.6 billion as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 5.94% to $3.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 billion through Dec 2025, down 5.94% year-over-year, with the annual reading at $3.6 billion for FY2025, 5.94% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $3.6 billion at Pfizer, up from $3.0 billion in the prior quarter.
  • The five-year high for Accumulated Expenses was $3.8 billion in Q4 2024, with the low at $2.0 billion in Q3 2023.
  • Average Accumulated Expenses over 5 years is $2.7 billion, with a median of $2.6 billion recorded in 2021.
  • The sharpest move saw Accumulated Expenses decreased 18.52% in 2023, then soared 42.62% in 2024.
  • Over 5 years, Accumulated Expenses stood at $3.3 billion in 2021, then grew by 2.25% to $3.4 billion in 2022, then decreased by 18.52% to $2.8 billion in 2023, then skyrocketed by 38.26% to $3.8 billion in 2024, then dropped by 5.94% to $3.6 billion in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $3.6 billion, $3.0 billion, and $2.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.